MedTrace Logo

Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection

NCT04542876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-09-09

No results posted yet for this study

Summary

The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19

Conditions

  • Covid19

Interventions

DRUG

Guduchi Ghan Vati

Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks.

Sponsors & Collaborators

  • Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

    collaborator OTHER

  • Aarogyam UK

    lead OTHER

Principal Investigators

  • Abhimanyu Kumar · Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

  • Neha Sharma · Aarogyam UK

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-07-31
Completion
2020-08-18

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542876 on ClinicalTrials.gov